Skip to main content
Weiter zur Homepage der Europäischen Kommission (öffnet in neuem Fenster)
Deutsch de
CORDIS - Forschungsergebnisse der EU
CORDIS

Lab-Protect: Translating phyllosphere-adapted microbial insights into a new class of lactobacilli-based biocontrol solutions

Ziel

Transitioning to sustainable crop protection is a pillar of the European Green Deal, calling for a 50% reduction in chemical pesticide use by 2030. This requires reliable, field-robust biological alternatives. LAB-Protect builds on the ERC StG Lacto Be and aims to develop next-generation microbial biocontrol agents (MBCAs) based on plant-derived lactic acid bacteria (LAB), an underexploited yet highly promising class of beneficial microbes. One lead strain isolated from strawberry tissue shows exceptionally potent inhibition of fungal and bacterial plant pathogens and retains its antagonistic activity after spray-drying, enabling stable formulation and long-term storage. Importantly, this strain demonstrated robust disease suppression directly on plants, overcoming the major bottleneck where most MBCAs fail to translate from in vitro assays to real plant systems. Additional plant-associated LAB strains show complementary biocontrol and formulation traits, further expanding the technology’s potential. LAB-Protect focuses on de-risking and strengthening the innovation potential of this technology. Specifically, we will (i) substantiate the strain’s previously observed in silico safety profile through, among others, targeted cell-line experiments and consulting with the European responsible authorities to support fast-track regulation, (ii) elucidate the mode of action underlying its potent antipathogenic activity and identify the chemical structure of the bioactive metabolite responsible, and (iii) scale up and validate in planta efficacy in additional crop-pathogen systems to demonstrate multi-crop applicability. These activities will elevate the technology beyond its current proof-of-concept stage, reinforce IP positioning, and attract industrial capital. Our ultimate goal is to deliver a differentiated, patent-protected biocontrol product and secure commercial deployment through a spin-off or licensing partnership.

Wissenschaftliches Gebiet (EuroSciVoc)

Schlüsselbegriffe

Programm/Programme

Thema/Themen

Finanzierungsplan

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

Alle im Rahmen dieses Finanzierungsinstruments finanzierten Projekte anzeigen

Aufforderung zur Vorschlagseinreichung

(öffnet in neuem Fenster) ERC-2026-POC

Alle im Rahmen dieser Aufforderung zur Einreichung von Vorschlägen finanzierten Projekte anzeigen

Gastgebende Einrichtung

UNIVERSITEIT ANTWERPEN
Netto-EU-Beitrag
€ 150 000,00
Adresse
PRINSSTRAAT 13
2000 Antwerpen
Belgien
Region
Vlaams Gewest Prov. Antwerpen Arr. Antwerpen
Aktivitätstyp
Higher or Secondary Education Establishments
Links
Gesamtkosten
Keine Daten

Begünstigte (1)